We are live on ! Find out more
CCMU

Cheyne Capital Management (UK) Portfolio holdings

AUM $27.9M
1-Year Est. Return 36.14%
This Fund
S&P 500
This Quarter Est. Return
+4.33%
1 Year Est. Return
+36.14%
3 Year Est. Return
+35.61%
5 Year Est. Return
+211.68%
10 Year Est. Return
+661.99%
AUM
$213M
AUM Growth
-$96M
Cap. Flow
-$134M
Cap. Flow %
-62.74%
Top 10 Hldgs %
83.44%
Holding
98
New
15
Increased
2
Reduced
7
Closed
56

Sector Composition

1 Materials 17.26%
2 Energy 16.95%
3 Real Estate 12.93%
4 Communication Services 11.69%
5 Industrials 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUN icon
1
Sunoco
SUN
$13.9B
$36.1M 16.95%
+368,500
New +$14.1M
CYT
2
DELISTED
CYTEC INDS INC
CYT
$36.1M 16.94%
+488,937
New +$34.1M
BEE
3
DELISTED
STRATEGIC HOTELS & RESORTS, INC
BEE
$24.5M 11.51%
+1,777,481
New +$24.1M
CVC
4
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
$24.2M 11.36%
+746,549
New +$20.3M
PCP
5
DELISTED
PRECISION CASTPARTS CORP
PCP
$17.6M 8.24%
+76,500
New +$16.4M
ALTR
6
DELISTED
Altera Corp
ALTR
$15M 7.05%
300,097
-110,488
-27% -$5.49M
HME
7
DELISTED
HOME PROPERTIES, INC
HME
$14.1M 6.59%
+187,903
New +$13.9M
OREX
8
DELISTED
Orexigen Therapeutics, Inc.
OREX
$2.56M 1.2%
121,539
-26,866
-18% -$921K
WFC icon
9
Wells Fargo
WFC
$265B
$2.07M 0.97%
+40,315
New +$2.22M
NKTR icon
10
Nektar Therapeutics
NKTR
$2.31B
$1.89M 0.89%
11,487
-11,424
-50% -$2.02M
INFI
11
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$1.86M 0.87%
220,618
-129,986
-37% -$1.2M
ICPT
12
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.68M 0.79%
10,150
-14,593
-59% -$3.21M
RDNT icon
13
RadNet
RDNT
$4.89B
$1.55M 0.73%
280,000
+10,000
+4% +$64.5K
PLD icon
14
Prologis
PLD
$140B
$1.53M 0.72%
+39,268
New +$1.54M
DRE
15
DELISTED
Duke Realty Corp.
DRE
$1.51M 0.71%
+79,278
New +$1.52M
VNDA icon
16
Vanda Pharmaceuticals
VNDA
$327M
$1.23M 0.58%
109,000
+70,000
+179% +$856K
TRV icon
17
Travelers Companies
TRV
$78.5B
$1.09M 0.51%
+11,000
New +$1.12M
MA icon
18
Mastercard
MA
$480B
$1.08M 0.51%
+12,000
New +$1.13M
EPC icon
19
Edgewell Personal Care
EPC
$1.37B
$816K 0.38%
+10,000
New +$905K
CRTO icon
20
Criteo
CRTO
$1.13B
$698K 0.33%
+18,599
New +$851K
COOP
21
DELISTED
Mr. Cooper
COOP
$573K 0.27%
+18,333
New +$582K
ADMS
22
DELISTED
Adamas Pharmaceuticals
ADMS
$502K 0.24%
+30,000
New +$683K
INO icon
23
Inovio Pharmaceuticals
INO
$92.1M
$404K 0.19%
5,833
-7,500
-56% -$653K
KGC icon
24
Kinross Gold
KGC
$27B
$371K 0.17%
215,000
B
25
Barrick Mining
B
$58.5B
$318K 0.15%
50,000

Similar funds

Cheyne Capital Management (UK)'s Q3 2015 Portfolio in Review

As of Q3 2015, Cheyne Capital Management (UK) held 98 positions worth $213M, down 31% from $309M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Cheyne Capital Management (UK) withdrew a net $134M in Q3 2015, closing 56 positions and reducing 7 holdings. Its most notable exit was DIRECTV COM STK (DE), an estimated $42.4M position sold in full.

By sector, the portfolio is most concentrated in Materials at 17% of assets, up from 16% a quarter earlier, followed by Energy and Real Estate.

Against the trend, Cheyne Capital Management (UK) opened a new position in CYTEC INDS INC worth $36.1M.

  • Cheyne Capital Management (UK)'s largest Q3 2015 buy was CYTEC INDS INC: 488,937 shares worth $36.1M.
  • Cheyne Capital Management (UK) added most to Vanda Pharmaceuticals in Q3 2015, an estimated $856K increase.
  • Cheyne Capital Management (UK)'s biggest Q3 2015 reduction was Altera Corp, cutting an estimated $5.49M.
  • Cheyne Capital Management (UK) fully exited DIRECTV COM STK (DE) in Q3 2015, selling an estimated $42.4M.
  • Cheyne Capital Management (UK)'s ten largest holdings make up 83% of its $213M portfolio in Q3 2015.
  • Cheyne Capital Management (UK) opened 15 new positions and closed 56 in Q3 2015.
  • Cheyne Capital Management (UK)'s portfolio value fell 31% quarter-over-quarter to $213M.

Based on Cheyne Capital Management (UK)'s 13F filing for Q3 2015, filed 19 Oct 2015.